John Paul Bouffard, MD - Medicare Pathology in Berkeley Heights, NJ

John Paul Bouffard, MD is a medicare enrolled "Pathology - Anatomic Pathology & Clinical Pathology" physician in Berkeley Heights, New Jersey. He went to Uniformed Services Uhs Fe Hebert School Of Med and graduated in 1990 and has 34 years of diverse experience with area of expertise as Pathology. He is a member of the group practice Morristown Pathology Associates Pa and his current practice location is 1 Diamond Hill Rd Fl G, Berkeley Heights, New Jersey. You can reach out to his office (for appointments etc.) via phone at (908) 277-8699.

John Paul Bouffard is licensed to practice in New Jersey (license number 25MA08115900) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1306801931.

Contact Information

John Paul Bouffard, MD
1 Diamond Hill Rd Fl G,
Berkeley Heights, NJ 07922-2104
(908) 277-8699
(908) 673-7388



Physician's Profile

Full NameJohn Paul Bouffard
GenderMale
SpecialityPathology
Experience34 Years
Location1 Diamond Hill Rd Fl G, Berkeley Heights, New Jersey
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • John Paul Bouffard attended and graduated from Uniformed Services Uhs Fe Hebert School Of Med in 1990
  NPI Data:
  • NPI Number: 1306801931
  • Provider Enumeration Date: 04/18/2006
  • Last Update Date: 05/09/2022
  Medicare PECOS Information:
  • PECOS PAC ID: 2365406022
  • Enrollment ID: I20070405000026

Medical Identifiers

Medical identifiers for John Paul Bouffard such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1306801931NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207ZN0500XPathology - Neuropathology 25MA08115900 (New Jersey)Secondary
207ZP0102XPathology - Anatomic Pathology & Clinical Pathology 25MA08115900 (New Jersey)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Overlook Medical CenterSummit, NJHospital
Morristown Medical CenterMorristown, NJHospital
Chilton Medical CenterPompton plains, NJHospital
Newton Medical CenterNewton, NJHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Morristown Pathology Associates Pa498169971729

News Archive

Axumin approved for use in PET scans in patients with recurrent prostate cancer

The U.S. Food and Drug Administration today approved Axumin, a radioactive diagnostic agent for injection. Axumin is indicated for positron emission tomography (PET) imaging in men with suspected prostate cancer recurrence based on elevated prostate specific antigen (PSA) levels following prior treatment.

Sildenafil plus recreational drugs equals risky sexual behaviour

A new survey has found that a significant number of young men have used erectile dysfunction, (ED), medications such as Viagra often in conjunction with other recreational drugs, and most without consulting a physician.

EMA grants orphan designations to Ultragenyx UX001, UX003 for treatment of HIBM and MPS 7

Ultragenyx Pharmaceutical Inc., a biotechnology company focused on developing treatments for rare and ultra-rare genetic disorders, today announced that the European Medicines Agency (EMA) has granted orphan drug designations for sialic acid for the treatment of hereditary inclusion body myopathy (HIBM) and recombinant human beta-glucuronidase for the treatment of mucopolysaccharidosis type 7.

Experimental co-culture approach facilitates study of cellular events underlying Huntington's disease

Using an experimental co-culture approach in which two different types of neurons from a mouse model of Huntington's disease (HD) are grown side-by-side, connecting to form critically impacted circuits, researchers at University of California San Diego School of Medicine have identified a subunit of a protein that, when expressed, reverse the mutated gene effects responsible for HD.

Virco Lab launches HIV/AIDS EHR technology

Virco Lab, Inc., the U.S. affiliate of Virco BVBA, today announced the launch of AVIGA and AVIGA REPORTER. AVIGA is a web-based electronic health record (EHR) solution with HIV/AIDS disease-specific functionality and AVIGA REPORTER is a web-based, data-reporting module designed specifically for the purposes of conducting HIV/AIDS research and providing reporting capabilities.

Read more Medical News

› Verified 2 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. John Paul Bouffard allows following entities to bill medicare on his behalf.
Entity NameSummit Medical Group Pa
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1942254347
PECOS PAC ID: 5395642276
Enrollment ID: O20031218000011

News Archive

Axumin approved for use in PET scans in patients with recurrent prostate cancer

The U.S. Food and Drug Administration today approved Axumin, a radioactive diagnostic agent for injection. Axumin is indicated for positron emission tomography (PET) imaging in men with suspected prostate cancer recurrence based on elevated prostate specific antigen (PSA) levels following prior treatment.

Sildenafil plus recreational drugs equals risky sexual behaviour

A new survey has found that a significant number of young men have used erectile dysfunction, (ED), medications such as Viagra often in conjunction with other recreational drugs, and most without consulting a physician.

EMA grants orphan designations to Ultragenyx UX001, UX003 for treatment of HIBM and MPS 7

Ultragenyx Pharmaceutical Inc., a biotechnology company focused on developing treatments for rare and ultra-rare genetic disorders, today announced that the European Medicines Agency (EMA) has granted orphan drug designations for sialic acid for the treatment of hereditary inclusion body myopathy (HIBM) and recombinant human beta-glucuronidase for the treatment of mucopolysaccharidosis type 7.

Experimental co-culture approach facilitates study of cellular events underlying Huntington's disease

Using an experimental co-culture approach in which two different types of neurons from a mouse model of Huntington's disease (HD) are grown side-by-side, connecting to form critically impacted circuits, researchers at University of California San Diego School of Medicine have identified a subunit of a protein that, when expressed, reverse the mutated gene effects responsible for HD.

Virco Lab launches HIV/AIDS EHR technology

Virco Lab, Inc., the U.S. affiliate of Virco BVBA, today announced the launch of AVIGA and AVIGA REPORTER. AVIGA is a web-based electronic health record (EHR) solution with HIV/AIDS disease-specific functionality and AVIGA REPORTER is a web-based, data-reporting module designed specifically for the purposes of conducting HIV/AIDS research and providing reporting capabilities.

Read more Medical News

› Verified 2 days ago

Entity NameMorristown Pathology Associates Pa
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1922075886
PECOS PAC ID: 4981699717
Enrollment ID: O20040420000045

News Archive

Axumin approved for use in PET scans in patients with recurrent prostate cancer

The U.S. Food and Drug Administration today approved Axumin, a radioactive diagnostic agent for injection. Axumin is indicated for positron emission tomography (PET) imaging in men with suspected prostate cancer recurrence based on elevated prostate specific antigen (PSA) levels following prior treatment.

Sildenafil plus recreational drugs equals risky sexual behaviour

A new survey has found that a significant number of young men have used erectile dysfunction, (ED), medications such as Viagra often in conjunction with other recreational drugs, and most without consulting a physician.

EMA grants orphan designations to Ultragenyx UX001, UX003 for treatment of HIBM and MPS 7

Ultragenyx Pharmaceutical Inc., a biotechnology company focused on developing treatments for rare and ultra-rare genetic disorders, today announced that the European Medicines Agency (EMA) has granted orphan drug designations for sialic acid for the treatment of hereditary inclusion body myopathy (HIBM) and recombinant human beta-glucuronidase for the treatment of mucopolysaccharidosis type 7.

Experimental co-culture approach facilitates study of cellular events underlying Huntington's disease

Using an experimental co-culture approach in which two different types of neurons from a mouse model of Huntington's disease (HD) are grown side-by-side, connecting to form critically impacted circuits, researchers at University of California San Diego School of Medicine have identified a subunit of a protein that, when expressed, reverse the mutated gene effects responsible for HD.

Virco Lab launches HIV/AIDS EHR technology

Virco Lab, Inc., the U.S. affiliate of Virco BVBA, today announced the launch of AVIGA and AVIGA REPORTER. AVIGA is a web-based electronic health record (EHR) solution with HIV/AIDS disease-specific functionality and AVIGA REPORTER is a web-based, data-reporting module designed specifically for the purposes of conducting HIV/AIDS research and providing reporting capabilities.

Read more Medical News

› Verified 2 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. John Paul Bouffard is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
John Paul Bouffard, MD
1 Diamond Hill Rd,
Berkeley Heights, NJ 07922-2104

Ph: () -
John Paul Bouffard, MD
1 Diamond Hill Rd Fl G,
Berkeley Heights, NJ 07922-2104

Ph: (908) 277-8699

News Archive

Axumin approved for use in PET scans in patients with recurrent prostate cancer

The U.S. Food and Drug Administration today approved Axumin, a radioactive diagnostic agent for injection. Axumin is indicated for positron emission tomography (PET) imaging in men with suspected prostate cancer recurrence based on elevated prostate specific antigen (PSA) levels following prior treatment.

Sildenafil plus recreational drugs equals risky sexual behaviour

A new survey has found that a significant number of young men have used erectile dysfunction, (ED), medications such as Viagra often in conjunction with other recreational drugs, and most without consulting a physician.

EMA grants orphan designations to Ultragenyx UX001, UX003 for treatment of HIBM and MPS 7

Ultragenyx Pharmaceutical Inc., a biotechnology company focused on developing treatments for rare and ultra-rare genetic disorders, today announced that the European Medicines Agency (EMA) has granted orphan drug designations for sialic acid for the treatment of hereditary inclusion body myopathy (HIBM) and recombinant human beta-glucuronidase for the treatment of mucopolysaccharidosis type 7.

Experimental co-culture approach facilitates study of cellular events underlying Huntington's disease

Using an experimental co-culture approach in which two different types of neurons from a mouse model of Huntington's disease (HD) are grown side-by-side, connecting to form critically impacted circuits, researchers at University of California San Diego School of Medicine have identified a subunit of a protein that, when expressed, reverse the mutated gene effects responsible for HD.

Virco Lab launches HIV/AIDS EHR technology

Virco Lab, Inc., the U.S. affiliate of Virco BVBA, today announced the launch of AVIGA and AVIGA REPORTER. AVIGA is a web-based electronic health record (EHR) solution with HIV/AIDS disease-specific functionality and AVIGA REPORTER is a web-based, data-reporting module designed specifically for the purposes of conducting HIV/AIDS research and providing reporting capabilities.

Read more News

› Verified 2 days ago


Pathology Doctors in Berkeley Heights, NJ

Nikolay D Dimov, MD
Pathology
Medicare: Accepting Medicare Assignments
Practice Location: 1 Diamond Hill Rd, Berkeley Heights, NJ 07922
Phone: 908-277-8699    Fax: 908-673-7388
Mr. Ara Meradian, MD
Pathology
Medicare: Accepting Medicare Assignments
Practice Location: 1 Diamond Hill Rd, Berkeley Heights, NJ 07922
Phone: 908-277-8699    Fax: 908-673-7388
Gabriel S Levi, MD
Pathology
Medicare: Accepting Medicare Assignments
Practice Location: 1 Diamond Hill Rd Fl G, Berkeley Heights, NJ 07922
Phone: 908-277-8699    Fax: 908-673-7388
Anup Hazra,
Pathology
Medicare: Medicare Enrolled
Practice Location: 1 Diamond Hill Rd, Berkeley Heights, NJ 07922
Phone: 908-273-4300    Fax: 908-277-8756
Fang Qian, M.D.
Pathology
Medicare: Accepting Medicare Assignments
Practice Location: 1 Diamond Hill Rd, Berkeley Heights, NJ 07922
Phone: 908-273-4300    
Rachel C Ochs, M.D.
Pathology
Medicare: Accepting Medicare Assignments
Practice Location: 1 Diamond Hill Rd, Berkeley Heights, NJ 07922
Phone: 908-273-4300    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.